Nicholas Khadder

Nicholas Khadder (senior executive) discloses dealings in 3 companies, chiefly Standard Biotools Inc., Amyris, Inc. and Cooper Companies, Inc. We count 57 filings; the first trade dates from 1 April 2016 and the latest from 8 January 2025.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 10 January 2025: an option exercise, in Cooper Companies, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.